Euphoria Formulation Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Euphoria Formulation Private Limited

Euphoria Formulation Private Limited, a active private limited company, was established on 16 June 2005 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397MH2005PTC154012. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Nikhil Jain (Director), Mishrimal Valchand Jain (Director). Past directors included Bhavesh Jayantilal Shah, Chirag Jain, Nikhil Jain. It holds ₹2.07 Cr open charges and ₹2.00 M settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1/12,Varma Nagar, Old Nagardas Road, Andheri East,, Mumbai, Maharashtra, 400069.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397MH2005PTC154012

  • Registration Number

    154012

  • Incorporation Date

    16 June 2005

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 20 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.07 Cr
  • Satisfied Charges ₹ 2.00 M
  • Revenue Growth **** 3.37%
  • Profit Growth **** 19.05%
  • Ebitda **** -23.33%
  • Net Worth 27.58%
  • Total Assets **** 19.17%
Company report

Euphoria Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Euphoria Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Euphoria Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Nikhil Jain Director 21 Jun 2011 Current
Mishrimal Valchand Jain Director 08 Sep 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jun 2010 Past
Pramod Abcsdd Director 23 Jun 2011 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Euphoria Formulation.

Euphoria Formulation Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial improvement in profitability, with a 19.05% increase in profit. The company's net worth Soared by an impressive increase of 27.58%.

Euphoria Formulation revenue growth over time
Euphoria Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.37%
*******
*******
*******
*******
Revenue from Operations
*******
 2.66%
*******
*******
*******
*******
Total Assets
*******
 19.17%
*******
*******
*******
*******
Profit or Loss
*******
 19.05%
*******
*******
*******
*******
Net Worth
*******
 27.58%
*******
*******
*******
*******
EBITDA
*******
 -23.33%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Euphoria Formulation?

Unlock access to Euphoria Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,695,000.00

Satisfied Charges

₹2,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.07 Cr
Latest Charge Details
Date Lender Amount Status
09 Jun 2010 Others ₹2.07 Cr Open
23 Feb 2006 Vijaya Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Euphoria Formulation?

Unlock and access historical data on people associated with Euphoria Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Euphoria Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euphoria Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Euphoria Formulation
Recent Activity within the Organization
  • Annual General Meeting

    The activity Euphoria Formulation Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Euphoria Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 20.70 M registered on 09 Jun 2010 with Charge ID 10230991 was modified on 16 Jun 2020. was recorded as a recent event.

  • Charges

    A charge registered on 23 Feb 2006 via Charge ID 90354693 with Vijaya Bank was fully satisfied on 01 Jul 2011. was recorded as a recent event.

  • Director Appointment

    Nikhil Jain was appointed as a Director was appointed as a Director on 21 Jun 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 20.70 M with Charge ID 10230991 was registered on 09 Jun 2010. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Euphoria Formulation Private Limited?

The CIN of Euphoria Formulation Private Limited is U51397MH2005PTC154012.

Where is Euphoria Formulation Private Limited headquartered?

Euphoria Formulation Private Limited is headquartered at 1/12,Varma Nagar, Old Nagardas Road, Andheri East,, Mumbai, Maharashtra, 400069.

When was Euphoria Formulation Private Limited incorporated?

Euphoria Formulation Private Limited was incorporated on 16 June 2005.

Who are the current directors of Euphoria Formulation Private Limited?

The current directors of Euphoria Formulation Private Limited are

What is the primary industry of Euphoria Formulation Private Limited?

The primary industry of Euphoria Formulation Private Limited is Trade.

Is Euphoria Formulation Private Limited a listed company?

Euphoria Formulation Private Limited is unlisted.

What is the capital structure of Euphoria Formulation Private Limited?

The authorized capital of Euphoria Formulation Private Limited is ₹2.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Euphoria Formulation Private Limited?

The compliance status of Euphoria Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available